Anzeige
Mehr »
Mittwoch, 15.04.2026 - Börsentäglich über 12.000 News
Unter dem Radar, voll finanziert: Beginnt jetzt der nächste Gold-Run?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DFJP | ISIN: US65345B2016 | Ticker-Symbol:
NASDAQ
14.04.26 | 20:58
0,425 US-Dollar
-1,19 % -0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXALIN TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
NEXALIN TECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur NEXALIN TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoNexalin Technology, Inc.: Nexalin Announces Peer-Reviewed Study Showing the Company's DIFS Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents1
DoEXCLUSIVE: Nexalin Study Flags Reduced Self-Injury In Adolescents Using Brain Stimulation Device2
25.03.Nexalin Technology, Inc. - 10-K, Annual Report3
25.02.Nexalin Technology, Inc. - 8-K, Current Report1
24.02.Nexalin Technology, Inc.: Nexalin Announces Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market571150-Patient, Triple-Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission for Drug-Free Insomnia Treatment Builds on Prior Peer-Reviewed...
► Artikel lesen
24.02.EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia3
NEXALIN TECHNOLOGY Aktie jetzt für 0€ handeln
23.02.Nexalin Technology, Inc.: Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders1
13.02.RedChip Companies, Inc.: Nexalin Technology and First Phosphate Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV926ORLANDO, FL / ACCESS Newswire / February 13, 2026 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and First Phosphate Corp. (CSE:PHOS)(OTCQX:FRSPF)(FSE:KD0) on the...
► Artikel lesen
05.02.Nexalin Technology, Inc.: Nexalin Launches NeuroCare, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer's, Mood Disorders, TBI & PTSD Care2
05.02.EXCLUSIVE: Nexalin Launches AI-Powered Virtual Clinic For Brain Health For Home Settings1
02.02.Nexalin reports brain imaging studies validate its neurostimulation tech1
02.02.Nexalin Technology, Inc.: Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS Technology as the Leader in Evidenced-Based Non-Invasive Brain Stimulation5
23.01.Nexalin erhält Rüge der NASDAQ wegen Nichterfüllung der Mindestkursanforderung2
23.01.Nexalin receives Nasdaq minimum bid price deficiency notice3
23.01.Nexalin Technology receives Nasdaq bid price deficiency notice2
23.01.Nexalin Technology, Inc. - 8-K, Current Report1
23.01.Nexalin Technology, Inc.: Nexalin Technology Receives Nasdaq Listing Status Notification223HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the "Company" or "Nexalin"), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS) of the...
► Artikel lesen
14.01.Nexalin Technology, Inc.: Published Peer-Reviewed Study Demonstrates Nexalin's DIFS Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD1
05.12.25Nexalin Technology, Inc. - 8-K, Current Report5
03.12.25Nexalin erzielt Fortschritt bei FDA-Zulassung für Alzheimer-Gerät2
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1